• Skip to main content
Scientific Sessions
Scientific Sessions Conference Coverage logo
  • Program
  • #ScientificSessions26
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Oct 19th, 2022

Saturday's Main Events

Today's Main Events highlight the best of the best breakthroughs in cardiovascular health and introduce distinguished researchers.


Crowded auditorium with multiple screens featuring speaker

Today’s scheduled Main Events

(Check the mobile meeting app for the complete schedule.)

Opening Session: Moving Science Into Public Health: Lessons Learned

Nov. 5 | 8 a.m. | Main Event I

The Main Event: Changing Clinical Practice

Nov. 5 | 9:30-10:30 a.m. | Main Event I

Annual Dr. Nanette K. Wenger Research Goes Red® Award for Best Scientific Article on Cardiovascular Disease and Stroke in Women

Nov. 5 | 11 a.m. | Main Event II

Global Innovations to Transform the Medical Workforce: Addressing Unmet Cardiovascular and Other Health Needs

Nov. 5 | 11 a.m. | Main Event I

Visualizing COVID for the Long Haul: Heart-Vasculature-Brain

Nov. 5 | 11 a.m. | Main Event III

Distinguished Scientist Lecture

Nov. 5 | 3 p.m. | Main Event III

Not Your Father's Heart Disease: Microvascular Coronary Function and Its Contribution to Disease

Nov. 5 | 3 p.m. | Main Event II

Identifying and Practicing Emerging Genomic-Based Therapies on Cardiovascular Disease

Nov. 5 | 4:30 p.m. | Main Event III

One Brave Idea — Redefining Coronary Heart Disease at the Edge of Wellness

Nov. 5 | 4:30 p.m. | Main Event I

Implementing the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization Into Real-World Practice

Nov. 5 | 4:30 p.m. | Main Event II

Interesting Stories
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Sponsored by Novartis Pharmaceuticals Corporation
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Prompt referral can be lifesaving
Sponsored by Edwards Lifesciences
Prompt referral can be lifesaving
More Content
audience
AHA22
Early ablation bests medication in treatment naïve AFib patients
Nov 9th, 2022
audience shot
AHA22
First-in-class aminopeptidase-A inhibitor fails to reduce treatment-resistant hypertension
Nov 9th, 2022
Manesh Patel
AHA22
#AHA 22 Closing Session: That’s a wrap
Nov 9th, 2022
Getty Images 1388100332
AHA22
Congratulations to the winners of the Wellness Challenge and Scavenger Hunt
Nov 8th, 2022
puppy snugglers
AHA22
Special Recognition to the Hinsdale Humane Society
Nov 8th, 2022
audience shot
AHA22
Trial results shed light on tool for assessing VTE risk, routine anticoagulation for non-hospitalized COVID patients, and clinical outcomes of open vs. endovascular surgery for advanced PAD
Nov 8th, 2022
LBS 05 panelists
AHA22
Trials’ results highlight supplement ineffectiveness and potential for novel therapies to lower lipoprotein(a), reduce CKD progression
Nov 8th, 2022
Medtech
AHA22
Medtech is getting smarter — and so is patient care
Nov 7th, 2022
med tech checking fluids in a hospital
AHA22
New digital hub offers professional education to complement lifelong learning
Nov 7th, 2022
AHA speaker dais
AHA22
Uncovering novel approaches in heart failure science
Nov 7th, 2022
Aha22 Sm 2334
AHA22
Trial results report on benefits of radial artery for CABG, use of prophylactic methylprednisolone and ECMO for patients in cardiogenic shock
Nov 7th, 2022
Screen Shot 2022 11 06 At 10 45 03 Am
AHA22
Science, medicine must be a ‘relentless force’ in fighting misinformation
Nov 6th, 2022